Terminated PHASE4 INTERVENTIONAL 2-arm NCT03614052

Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy

Efectividad de la Tamsulosina Como Tratamiento Adyuvante Previo a Ureterolitotomia Endoscopica

Sponsor: Pontificia Universidad Catolica de Chile

Conditions Ureteral Calculi Ureterolithiasis Urolithiasis

Interventions Placebo Oral Tablet Tamsulosin Hydrochloride 0.4 milligrams

Updated 6 times since 2018 Last updated: Jan 29, 2020 Started: Jun 1, 2018 Primary completion: Jan 26, 2020 Completion: Jan 26, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Problems with the number of participants

Other terminated trials from Pontificia Universidad Catolica de Chile

See all terminations from Pontificia Universidad Catolica de Chile

This PHASE4 trial investigates Ureteral Calculi and Ureterolithiasis and is currently terminated or withdrawn. Pontificia Universidad Catolica de Chile leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Feb 2020 — Jan 2021 [monthly]

Terminated PHASE4

Status: Recruiting → Terminated
May 2019 — Feb 2020 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Sep 2018 — May 2019 [monthly]

Recruiting PHASE4

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pontificia Universidad Catolica de Chile

Data source: Pontificia Universidad Catolica de Chile

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago, Chile